Is your organization missing from this list? Reach out to Leyla Cakici, Strategic Alliance Partnership Coordinator, to learn more about the complimentary strategic partnership program: lcakici@mjhlifesciences.com
Adding CAN-2409 to radiation significantly extends DFS in localized prostate cancer
Subgroup analysis evaluates darolutamide in previously treated mCRPC
Phase 3 ARASTEP study to evaluate PSMA PET-CT–detected BCR in prostate cancer
Pearls & Perspectives: Understanding and Improving Pelvic Health, with Diane Newman, DNP